Contribution: Industrial Research Assistance Program
Sciences Cinq Prime Incorporée/Five Prime Sciences Incorporated
$500,000.00
MNC Collab- Liver si-RNA-Novel Targets for si-RNA therapeutics and automation of analysis pipelines
FY 2025-26 · 2026-01-15
Summary
As part of the international consortium project “Liver si-RNA,” this project will focus on advanced computational methods to accelerate discovery and validation of drug targets and biomarkers, using human genetics, integrated with protein and metabolite datasets.
Department
Program
Industrial Research Assistance Program
Location
Westmount|Westmount, Quebec, Canada
Recipient Type
For-profit organization
Business Number
784295503
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2028-01-14
Agreement Number
1039741
Agreement Start Date
2026-01-15
Agreement Title
MNC Collab- Liver si-RNA-Novel Targets for si-RNA therapeutics and automation of analysis pipelines
Agreement Title (French)
PCM - Liver si-RNA - Nouvelles cibles pour les thérapies à base d’ARN interférent et automatisation des pipelines d’analyse
Agreement Type
Contribution
Agreement Value
$500,000.00
Amendment Number
0
Coverage
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity. | Les projets du Programme d'aide à la recherche industrielle favorisent la création de richesse au Canada grâce à l'innovation technologique et renforcent l'écosystème canadien de l'innovation en créant de nouvelles capacités industrielles.
Description
As part of the international consortium project “Liver si-RNA,” this project will focus on advanced computational methods to accelerate discovery and validation of drug targets and biomarkers, using human genetics, integrated with protein and metabolite datasets.
Description (French)
Dans le cadre du projet de consortium international « Liver si-RNA », ce projet se concentrera sur des méthodes computationnelles avancées visant à accélérer la découverte et la validation de cibles médicamenteuses et de biomarqueurs, en utilisant la génétique humaine, intégrée à des ensembles de données sur les protéines et les métabolites.
Expected Results
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Expected Results (French)
Les résultats attendus du Programme d’aide à la recherche industrielle du CNRC sont axés sur la croissance des petites et moyennes entreprises (PME) grâce à l’innovation et à la création de richesse pour le Canada.
Federal Riding
Notre-Dame-de-Grâce--Westmount
Federal Riding (French)
Notre-Dame-de-Grâce--Westmount
Federal Riding Number
24053
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program
Program Name (French)
Programme d’aide à la recherche industrielle
Program Purpose
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Program Purpose (French)
Les contributions versées aux entreprises en vertu du Programme d’aide à la recherche industrielle ont pour objectif d’apporter un soutien aux petites et moyennes entreprises (PME) afin qu’elles puissent approfondir leurs connaissances en matière d’innovation et renforcer leur capacité d’innovation, de croissance et de création de richesse pour le Canada.
Recipient Business Number
784295503
Recipient City
Westmount|Westmount
Recipient Country
CA
Recipient Legal Name
Sciences Cinq Prime Incorporée/Five Prime Sciences Incorporated
Recipient Postal Code
H3Y 2W4
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2025-2026-Q4-1039741
